Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

MEDTRONIC VASCULAR, INC.

US

Last updated September 17, 2026

What MEDTRONIC VASCULAR, INC. makes

The company manufactures non-bioabsorbable soft-tissue mesh anchors, including systems and cassettes for endoscopic or minimally invasive fixation, such as the Heli-FX EndoAnchor System and its thoracic variants. It also produces an introducer sheath with a hydrophilic coating for procedural use.

These devices are regulated under FDA Class II and Class III classifications, with authorisation records in 510(k), PMA, and UDI registries. The company is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Medtronic Vascular, Inc. primarily manufacture?

Medtronic Vascular, Inc. specializes in non-bioabsorbable soft-tissue mesh anchors designed for endoscopic or minimally invasive surgical fixation. Their portfolio includes systems like the Heli-FX EndoAnchor System and its thoracic-specific variants, as well as ancillary components such as cassettes. Additionally, they produce procedural tools like the Sentrant Introducer Sheath with a hydrophilic coating, which reduces friction during insertion.

Where is Medtronic Vascular, Inc. based, and how does that affect its regulatory oversight?

Medtronic Vascular, Inc. is headquartered in the United States, which means its devices fall under the jurisdiction of the U.S. Food and Drug Administration (FDA). The FDA classifies these devices as either Class II or Class III, depending on their risk level and intended use, requiring pre-market authorisation through pathways like 510(k) clearances, Premarket Approvals (PMAs), or Unique Device Identification (UDI) registrations.

Which regulatory registries list Medtronic Vascular, Inc.’s devices, and why?

Medtronic Vascular, Inc.’s devices are listed in the FDA’s 510(k), PMA, and UDI registries. The 510(k) pathway applies to Class II devices deemed substantially equivalent to existing approved products, while Class III devices—often higher-risk—require a Premarket Approval (PMA) to demonstrate safety and effectiveness. The UDI registry ensures traceability and transparency in the supply chain, tracking devices throughout their lifecycle for compliance and recall purposes.

How are Medtronic Vascular, Inc.’s devices classified by the FDA, and what does that mean for their use?

The FDA classifies Medtronic Vascular, Inc.’s devices as either Class II or Class III. Class II devices, like some mesh anchors, typically require performance standards and 510(k) clearance to prove they’re as safe and effective as comparable legacy products. Class III devices, such as certain high-risk fixation systems, require a Premarket Approval (PMA) to demonstrate safety and efficacy through rigorous clinical trials, as they lack a predicate device or pose greater risks.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
3576 Unocal Pl, Santa Rosa, CA, 95403
Website
medtronic.com
LinkedIn
—
Facebook
—
Phone
+1(800)633-8766
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
3001452571
DUNS Number
080009661

Catalogue (509)

Page 2 of 11
DeviceModel / ReferenceRegistriesClassStatus
Medtronic Model 9443 In-Office Transmitter K894140
FDA 510(k)
Class IIActive
Myocardial Protection System K905500
FDA 510(k)
Class IIActive
Vascular Graft Package (shelf-Life Extension) K894732
FDA 510(k)
Class IIActive
Model 6495 Bipolar Temporary Pacing Lead K963898
FDA 510(k)
Class IIActive
Zuma Guide Catheters K000677
FDA 510(k)
Class IIActive
Medtronic Model 7728 Neuromod K792311
FDA 510(k)
Class IIActive
Modification To Model 5866-37m Lead Adaptor Kit K000210
FDA 510(k)
Class IIActive
Permanent Cardiac Pacing Leads And Adaptors K912464
FDA 510(k)
Class IIIActive
Implantable Pacing Leads W/Is-1 Conn., Unipolar K894040
FDA 510(k)
Class IIIActive
Medtronic #3484 Pisces Epidural Lead K812154
FDA 510(k)
Class IIActive
Model 6500 Unipolar Temorary Myocardial Pacing Lead K012452
FDA 510(k)
Class IIActive
Medtronic 6957j K843707
FDA 510(k)
Class IIIActive
Minix 834m & Minix St 8331m Pulse Generators (modification) K953866
FDA 510(k)
Class IIIActive
Model 6494 Unipolar Temporary Myocardial Pacing Wire K012459
FDA 510(k)
Class IIActive
Model 5857-3m Lead End Cap Kit K911048
FDA 510(k)
Class IIActive
Medtronic Access Port Model 8500 K853322
FDA 510(k)
Class IIActive
Medtronic Model 3530 Percutaneous Extension K892884
FDA 510(k)
Class IIActive
Modified Model 5401b Test Cable K900622
FDA 510(k)
Class IIIActive
Pellethane 75d K940039
FDA 510(k)
Class IIIActive
Alternate Sterlization Process & Modified Df-1 Lead Connector (modification) K954092
FDA 510(k)
Class IIIActive
Ventricular Leads K772203
FDA 510(k)
Class IIIActive
Polygram Net Biofeedback Application K041244
FDA 510(k)
Class IIActive
Dynex Iiib, Model 89002026 K913594
FDA 510(k)
Class IIActive
Model 3587a Resume Ii Lead K915540
FDA 510(k)
Class IIActive
Transvenous, Permanent Tined Target Tip Pacing Leads K951858
FDA 510(k)
Class IIIActive
Model 3587a Resume Epidural Lead K884948
FDA 510(k)
Class IIActive
Promeon Hydrogel Dressing #45 Sterile W/O Mesh K915357
FDA 510(k)
Class IActive
Ventricular Inhibited Pulse Generator K780561
FDA 510(k)
Class IIIActive
Eopa Cap Elongated One-Piece Arterial Cannula With Pressure Monitoring Line, Models 774xx, 775xx, 776xx, 777xx, 788xx, K031518
FDA 510(k)
Class IIActive
Model 5867-12 Bipolar Low-Profile Lead K812725
FDA 510(k)
Class IIActive
Temporary Myocardial Pacing Lead#6400 K810333
FDA 510(k)
Class IIIActive
Model 3470 X-Trel Rf Receiver K943537
FDA 510(k)
Class IIActive
Cardiac Pulse Generators 5982/5983 K771786
FDA 510(k)
Class IIIActive
Cf Indicator Model 9800 Sweat Test System K895775
FDA 510(k)
Class IIActive
Export Catheter K040869
FDA 510(k)
Class IIActive
Medtronic Mdls 3487/3487a/3587/3587a Scs Leads K914433
FDA 510(k)
Class IIActive
Unipolar Pediatric Temporary Pacing Lead Mod. 6491 K922268
FDA 510(k)
Class IIActive
Medtronic Models 4012 & 4512 K832099
FDA 510(k)
Class IIIActive
Comfort-Ease Electrode K851303
FDA 510(k)
Class IIActive
Medtronic Enertrax Model 7100 K812096
FDA 510(k)
Class IIIActive
Medtronic 5064 K851890
FDA 510(k)
Class IIActive
6248val Adjustable Valve K052459
FDA 510(k)
Class IIActive
Vacuum Bake Cycle K904892
FDA 510(k)
Class IIIActive
Model 6416 Temporary Pacing Lead System K042190
FDA 510(k)
Class IIActive
Metronic Model F7700 Heart Valve Sizers K852612
FDA 510(k)
Class IActive
6F Sherpa NX Balanced Guide Catheter, 7F Sherpa NX Balanced Guide Catheter K232190
FDA 510(k)
Class IIActive
Medtronis(r) Pacing Leads And Lead Adaptors, Modif K933055
FDA 510(k)
Class IIIActive
Generator, Pulse Models 5920/5921 K780809
FDA 510(k)
Class IIIActive
Pacific Plus K123358
FDA 510(k)
Class IIActive
Medtronic Model 5328 Program-Stimulator K851091
FDA 510(k)
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (100)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Medtronic Vascular, Inc. has 234 recall records spanning from June 8, 2004, to March 23, 2022, with statuses recorded as open, classified, or terminated. The reasons cited include mechanical failures such as detachment of spindle components, radiopaque marker bonds, or taper tips during stent graft deployment; labeling errors such as incorrect usable lengths, master labels, and stentstop assemblies; sterility concerns due to compromised package integrity; and manufacturing defects like retained manufacturing materials in embolization systems. Some records reference procedural complications, such as difficulty flushing delivery systems or potential endoleaks and stent fractures.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Mar 23, 2022Z-1043-2022—open, classified

Packaging for Balloon Catheters may be damaged resulting in loss of sterility.

Mar 23, 2022Z-1042-2022—open, classified

Packaging for Balloon Catheters may be damaged resulting in loss of sterility.

Dec 21, 2021Z-0657-2022—open, classified

Stent Graft Systems built with specific batches of taper tip assemblies have the potential for the taper tip to detach from the delivery system. Detachment of the taper tip during the implant procedure may lead to a secondary intervention to attempt to remove the taper tip, either by endovascular retrieval or surgical conversion. There is also potential that the taper tip is intentionally left behind in the patient, at the physician's discretion, if not easily removable.

Oct 15, 2021Z-0291-2022—open, classified

Due to, during stent graft deployment, the spindle may detach from the distal end of the spindle hypotube.

Oct 15, 2021Z-0292-2022—open, classified

Due to, during stent graft deployment, the spindle may detach from the distal end of the spindle hypotube.

Oct 15, 2021Z-0290-2022—open, classified

During stent graft deployment, the spindle may detach from the distal end of the spindle hypotube

Jun 7, 2021Z-2135-2021—open, classified

During stent graft deployment, the radiopaque (RO) marker bond detached from the distal end of the graft cover.

Jun 7, 2021Z-2136-2021—open, classified

During product complaint investigation, it was determined that during stent graft deployment, the radiopaque (RO) marker bond detached from the distal end of the graft cover.

May 4, 2021Z-1860-2021—terminated

The component part numbers intended for shipment to a third-party, where they are further processed into kits and sterilized were instead shipped directly to customers.

Apr 28, 2021Z-1976-2021—terminated

Incorrect stentstop assembly (18fr) was used to build the delivery system component of the device. Correct stentstop assembly is 20fr.

Feb 12, 2021Z-1201-2021—open, classified

Due to the presence of type IIIb endoleaks, stent fractures, and stent ring enlargement.

Jan 15, 2021Z-1248-2021—terminated

Sterility may be compromised due to an unsealed pouch

Jan 15, 2021Z-1245-2021—terminated

Sterility may be compromised due to an unsealed pouch

Jan 15, 2021Z-1246-2021—terminated

Sterility may be compromised due to an unsealed pouch

Jan 15, 2021Z-1247-2021—terminated

Sterility may be compromised due to an unsealed pouch

Aug 25, 2020Z-0088-2021—terminated

Subsequent failure of catheters in the field and failed quality testing

Aug 25, 2020Z-0087-2021—terminated

Subsequent failure of catheters in the field and failed quality testing

Aug 25, 2020Z-0089-2021—terminated

Subsequent failure of catheters in the field and failed quality testing

Mar 15, 2019Z-2605-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2644-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2651-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2749-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2698-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2699-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2732-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2643-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2579-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2574-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2709-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2589-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2575-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2674-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2591-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2604-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2603-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2738-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2562-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2750-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2686-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2688-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2621-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2684-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2721-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2744-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2682-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2733-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2656-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2662-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2647-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2630-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2565-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2654-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2649-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2571-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2635-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2576-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2626-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2692-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2611-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2714-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2633-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2578-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2600-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2618-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2583-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2636-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2752-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2596-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2581-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2726-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2632-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2672-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2593-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2568-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2685-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2652-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2671-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2639-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2585-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2680-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2638-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2710-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2719-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2646-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2718-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2564-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2742-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2594-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2664-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2715-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2717-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2736-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2658-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2650-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2592-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2569-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2597-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2634-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2712-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2747-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.